Chemotherapy‐induced peripheral neuropathy in African American cancer survivors: Risk factors and quality of life outcomes

Chemotherapy‐induced peripheral neuropathy in African American cancer survivors: Risk factors and quality of life outcomes

Abstract Background Epidemiological studies of chemotherapy‐induced peripheral neuropathy (CIPN) have predominantly focused on non‐Hispanic White patients, despite the observation that African Americans are more likely to experience CIPN. To address this health disparities gap, we sought to identify...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Matthew R. Trendowski, Christine M. Lusk, Julie J. Ruterbusch, Randell Seaton, Michael S. Simon, Mark K. Greenwald, Felicity W. K. Harper, Jennifer L. Beebe‐Dimmer, Ann G. Schwartz
Format: article
Langue:EN
Publié: Wiley 2021
Sujets:
African Americans
chemotherapy‐induced peripheral neuropathy
health disparities
quality of life
risk
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Accès en ligne:https://doaj.org/article/f7126e1a2b374146bee112253b537bb1
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/f7126e1a2b374146bee112253b537bb1

Documents similaires